Roots Analysis
JANUARY 23, 2024
Owing to the challenges involved in the synthesis process and demands of modern drug development, majority of drug developers in this domain prefer to outsource their development and manufacturing operations to peptide therapeutics contract API manufacturers as a strategic solution to streamline their research and peptide synthesis efforts.
The Pharma Data
AUGUST 20, 2020
DEVELOP A UNIFIED SCIENTIFIC VOICE. The latest results underscore that large pharma companies are making a “strategic retreat from some of their older drugs,” in China, ICBC International Research analyst Zhang Jialin said, as quoted by Bloomberg; instead, they’re focusing on growing market share for newer medicines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ACRP blog
NOVEMBER 8, 2023
“With retail pharmacies entering the clinical trial space, investigative sites are left with little information around how this move will affect them or their patients,” says Emily Botto, Senior Research Analyst at the Tufts Center for the Study of Drug Development (CSDD) and a scheduled presenter at the ACRP 2024 conference in Anaheim, Calif.
ACRP blog
NOVEMBER 8, 2023
“With retail pharmacies entering the clinical trial space, investigative sites are left with little information around how this move will affect them or their patients,” says Emily Botto, Senior Research Analyst at the Tufts Center for the Study of Drug Development (CSDD) and a scheduled presenter at the ACRP 2024 conference in Anaheim, Calif.
Roots Analysis
AUGUST 15, 2024
On the other hand, solutions available in the oncology molecular diagnostics market can identify cancer at a much earlier stage, in some cases, even before symptoms develop. Author Bio: Gaurav Raj Bangarh Gaurav Raj Bangarh is a business research analyst and competitive intelligence professional.
Roots Analysis
AUGUST 12, 2024
The figure pasted below shows the distribution of developers of synthetic leather based on company size. These innovations include the development of advanced bio-based materials and polymers, including polyurethane and polyvinyl chloride (PVC), which offer enhanced tear strength, abrasion resistance, and flexibility.
The Pharma Data
DECEMBER 28, 2020
28, 2020 /PRNewswire/ — Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist contract research organization (CRO) in Asia , today announced the appointment of Zidong Zhang as Chief Financial Officer (CFO) effective 4 January 2021. SHANGHAI and SYDNEY , Dec. ” ABOUT NOVOTECH HEALTH HOLDINGS.
Expert insights. Personalized for you.
40 
Let's personalize your content